Curis Inc (CRIS)
Official siteHEALTHCARE • BIOTECHNOLOGY • NASDAQ
Market Cap: $2.97M
Last updated: Nov 17, 2026 at 11:04 AM ET
Curis Inc (CRIS) Stock Forecast
Analysts expect Curis (CRIS) to earn -$23.78 per share in the fiscal year ending Dec 31, 2026. Of 4 analysts, 4 rate the stock Buy or Strong Buy, 0 Hold and 0 Sell or Strong Sell, for a consensus of Buy. Over the last 30 days, 1 estimate for the fiscal year ending Dec 31, 2026 was revised up and 0 down.
Analyst Ratings
Scoring Strong Buy as 1 and Strong Sell as 5, the 4 ratings average 1.75, inside the Buy band from 1.5 up to 2.5. Buy and Strong Buy make up 100% of the ratings.
| Rating | Analysts | Share |
|---|---|---|
| Strong Buy | 1 | 25.0% |
| Buy | 3 | 75.0% |
| Hold | 0 | 0.0% |
| Sell | 0 | 0.0% |
| Strong Sell | 0 | 0.0% |
- Consensus
- Buy
- Total analysts
- 4
Price Target
Analyst price targets are part of paid GNG plans. See plans
Annual Estimates
From the first fiscal year below to the second, the EPS consensus shows a smaller loss.
- Fiscal year ending Dec 31, 2026
- -$23.78
- EPS consensus
- Fiscal year ending Dec 31, 2027
- -$6.01
- EPS consensus, revenue $9.25M
- Next report
- Mar 17, 2027
- Estimated
EPS range
| Fiscal year ending | EPS consensus | EPS range | EPS analysts | Revenue consensus | Revenue range | Rev. analysts |
|---|---|---|---|---|---|---|
| Dec 31, 2026 | -$23.78 | -$32.48 to -$15.65 | 3 | N/A | N/A | 3 |
| Dec 31, 2027 | -$6.01 | -$7.99 to -$3.17 | 3 | $9.25M | N/A | 4 |
Quarterly Estimates
| Quarter ending | EPS consensus | EPS range | EPS analysts |
|---|---|---|---|
| Dec 31, 2026 | $2.98 | -$1.71 to $12.60 | 6 |
Estimate Revisions
Across the 2 periods below, the last 30 days brought 3 upward and 0 downward EPS revisions. Raises outnumber cuts in every period.
| Period | Up 30 days | Down 30 days |
|---|---|---|
| Fiscal year ending Dec 31, 2026 | 1 | 0 |
| Fiscal year ending Dec 31, 2027 | 2 | 0 |
EPS Trend
Over the last 90 days, the EPS consensus for the fiscal year ending Dec 31, 2026 has improved from -$31.20.
| Period | Now | 7 days ago | 30 days ago | 60 days ago | 90 days ago | Change |
|---|---|---|---|---|---|---|
| Fiscal year ending Dec 31, 2026 | -$23.78 | -$29.78 | -$31.20 | -$31.20 | -$31.20 | N/A |
| Fiscal year ending Dec 31, 2027 | -$6.01 | -$16.23 | -$23.73 | -$23.73 | -$23.73 | N/A |
Frequently Asked Questions About CRIS
What is the CRIS stock forecast?
Consensus analyst estimates put Curis's EPS at -$23.78 for the fiscal year ending Dec 31, 2026. The consensus rating from 4 analysts is Buy.
How do analysts rate CRIS stock?
Of 4 analysts covering Curis, 1 rates it Strong Buy, 3 Buy, 0 Hold, 0 Sell and 0 Strong Sell, for a consensus of Buy.
What EPS do analysts expect from CRIS next year?
For the fiscal year ending Dec 31, 2026, the consensus EPS estimate is -$23.78, with estimates from -$32.48 to -$15.65 from 3 analysts. For the fiscal year ending Dec 31, 2027, the consensus EPS estimate is -$6.01, with estimates from -$7.99 to -$3.17 from 3 analysts.
What revenue do analysts expect from Curis next year?
For the fiscal year ending Dec 31, 2027, the consensus revenue estimate is $9.25M.
How many analysts cover CRIS?
4 analysts rate Curis stock, and 3 analysts estimate its EPS for the fiscal year ending Dec 31, 2026.
CRIS pages: Overview, Earnings, Forecast, Financials, Competitors